WuXi in deal to develop Vir’s antibody against coronavirus
Vir Biotechnology turns to WuXi to support development and commercialization of an antibody-based potential treatment for the coronavirus.
Vir Biotechnology turns to WuXi to support development and commercialization of an antibody-based potential treatment for the coronavirus.
The latest Study Voices survey from BBK Worldwide indicates healthcare consumers and trial participants think alike towards technology, doctor access and quality of care.
The biopharma solutions firm is expanding its footprint with new sales and marketing partners in China, Korea and Israel.
Genentech and Bicycle partner for the development of small molecule, immuno-oncology targets.
Frontage has announced completion of its Pennsylvania site expansion to boost its offering of bioanalytical services for late-stage cell and gene therapies developers.
Merck to produce 3D-printed tablets by tapping into the technology developed by AMCM, making a move towards digitalization.